Skip to main content
  • Saved

Commented on 's Post

Real-world evidence of cytomegalovirus reactivation in non-Hodgkin lymphomas treated with bendamustine-containing regimens - PubMed

Real-world evidence of cytomegalovirus reactivation in non-Hodgkin lymphomas treated with bendamustine-containing regimens - PubMed

Source :

https://pubmed.ncbi.nlm.nih.gov/33981851/

Cytomegalovirus (CMV) reactivation during chemotherapy or after organ or hematopoietic stem cell transplantation is a major cause of morbidity and mortality, and the risk of reactivation increases with patients' age. Bendamustine, an alkylating agent currently used for treatment of indolent and aggr ...

  • 3 weeks
    This is not surprising data given the degree and duration of lymphopenia induced by bendamustine. Caution with this agent in the covid and car T era